Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time 2021-04-21 08:38
China Biologic Announces Completion of Going Private Transaction 2021-04-21 04:30
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005 2021-04-20 20:54
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day 2021-04-20 20:00
Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics 2021-04-20 09:00
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration 2021-04-20 08:30
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform 2021-04-20 05:00
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer 2021-04-20 01:42
AACR Annual Meeting 2021: AnchorDx Unveils High-Performance Blood Test for Gastric Cancer Screening 2021-04-19 21:00
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection 2021-04-19 20:15
Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy 2021-04-19 20:00
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC 2021-04-19 20:00
Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE 2021-04-19 17:54
RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China 2021-04-19 17:16
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer 2021-04-19 08:00
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC 2021-04-16 20:00
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting 2021-04-16 08:00
New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry 2021-04-15 21:00
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive 2021-04-15 16:30
Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma 2021-04-15 09:00
1 210 211 212 213 214 413